{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:41:41Z","timestamp":1791686501586,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008751","name":"Bundesinstitut f\u00fcr Risikobewertung","doi-asserted-by":"publisher","award":["1322-657"],"award-info":[{"award-number":["1322-657"]}],"id":[{"id":"10.13039\/501100008751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The liver is constantly exposed to mixtures of hepatotoxic compounds, such as food contaminants and pesticides. Dose addition is regularly assumed for mixtures in risk assessment, which however might not be sufficiently protective in case of synergistic effects. Especially the prediction of combination effects of substances which do not share a common adverse outcome (AO) might be problematic. In this study, the focus was on the endpoint liver triglyceride accumulation in vitro, an indicator of hepatic fatty acid changes. The hepatotoxic compounds difenoconazole, propiconazole and tebuconazole were chosen which cause hepatic fatty acid changes in vivo, whereas fludioxonil was chosen as a hepatotoxic substance not causing fatty acid changes. Triglyceride accumulation was analyzed for combinations of steatotic and non-steatotic pesticides in human HepaRG hepatocarcinoma cells. Investigations revealed a potentiation of triglyceride accumulation by mixtures of the steatotic compounds with the non-steatotic fludioxonil, as compared to the single compounds. Mathematical modeling of combination effects indicated more than additive effects for the tested combinations if the method by Chou was applied, and a decrease in EC<jats:sub>50<\/jats:sub> values of the steatotic compounds when applied in mixtures. Use of an adverse outcome pathway (AOP)-driven testing strategy for liver steatosis showed interactions of the test compounds with the nuclear receptors AHR, CAR and PXR, as well as a downregulation of <jats:italic>ACOX2<\/jats:italic>. An ACOX2-dependent mechanism underlying the observed mixture effect could not be verified using a siRNA approach. By contrast, a toxicokinetic interaction was identified including an inhibition of the metabolic enzyme CYP3A4 by fludioxonil and a decreased metabolic conversion of the CYP3A4 substrate difenoconazole when used in mixture experiments. In conclusion, an interaction by a steatotic and a non-steatotic compound at the toxicokinetic level on the endpoint triglyceride accumulation in vitro was described.<\/jats:p>","DOI":"10.1007\/s00204-021-02997-2","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T18:05:44Z","timestamp":1613066744000},"page":"1397-1411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells"],"prefix":"10.1007","volume":"95","author":[{"given":"Alexandra","family":"Lasch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Marx-Stoelting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3810-027X","authenticated-orcid":false,"given":"Albert","family":"Braeuning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajana","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"2997_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0192623314549960","volume":"43","author":"L Al-Eryani","year":"2015","unstructured":"Al-Eryani L, Wahlang B, Falkner KC, Guardiola JJ, Clair HB, Prough RA, Cave M (2015) Identification of environmental chemicals associated with the development of toxicant-associated fatty liver disease in rodents. Toxicol Pathol 43:482\u2013497. https:\/\/doi.org\/10.1177\/0192623314549960","journal-title":"Toxicol Pathol"},{"key":"2997_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/etc.34","volume":"29","author":"GT Ankley","year":"2010","unstructured":"Ankley GT et al (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730\u2013741. https:\/\/doi.org\/10.1002\/etc.34","journal-title":"Environ Toxicol Chem"},{"key":"2997_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1124\/dmd.109.030197","volume":"38","author":"S Antherieu","year":"2010","unstructured":"Antherieu S et al (2010) Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Metab Dispos 38:516\u2013525. https:\/\/doi.org\/10.1124\/dmd.109.030197","journal-title":"Drug Metab Dispos"},{"key":"2997_CR4","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1073\/pnas.93.24.13748","volume":"93","author":"E Baumgart","year":"1996","unstructured":"Baumgart E et al (1996) Molecular characterization of the human peroxisomal branched-chain acyl-CoA oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence for the absence of the protein in Zellweger syndrome. Proc Natl Acad Sci USA 93:13748\u201313753. https:\/\/doi.org\/10.1073\/pnas.93.24.13748","journal-title":"Proc Natl Acad Sci USA"},{"key":"2997_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/ieam.5630030307","volume":"3","author":"JB Belden","year":"2007","unstructured":"Belden JB, Gilliom RJ, Lydy MJ (2007) How well can we predict the toxicity of pesticide mixtures to aquatic life? Integr Environ Assess Manag Int J 3:364\u2013372","journal-title":"Integr Environ Assess Manag Int J"},{"key":"2997_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/1060028019896894","volume":"54","author":"T Cai","year":"2020","unstructured":"Cai T, Liao Y, Chen Z, Zhu Y, Qiu X (2020) the influence of different triazole antifungal agents on the pharmacokinetics of cyclophosphamide. Ann Pharmacother 54:676\u2013683. https:\/\/doi.org\/10.1177\/1060028019896894","journal-title":"Ann Pharmacother"},{"key":"2997_CR7","doi-asserted-by":"publisher","first-page":"e96580","DOI":"10.1371\/journal.pone.0096580","volume":"9","author":"N Cedergreen","year":"2014","unstructured":"Cedergreen N (2014) Quantifying synergy: a systematic review of mixture toxicity studies within environmental toxicology. PLoS ONE 9:e96580. https:\/\/doi.org\/10.1371\/journal.pone.0096580","journal-title":"PLoS ONE"},{"key":"2997_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11010-010-0583-6","volume":"345","author":"NK Chaturvedi","year":"2010","unstructured":"Chaturvedi NK, Kumar S, Negi S, Tyagi RK (2010) Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders. Mol Cell Biochem 345:291\u2013308. https:\/\/doi.org\/10.1007\/s11010-010-0583-6","journal-title":"Mol Cell Biochem"},{"key":"2997_CR9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621\u2013681. https:\/\/doi.org\/10.1124\/pr.58.3.10","journal-title":"Pharmacol Rev"},{"key":"2997_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/toxsci\/kfu120","volume":"141","author":"G de Sousa","year":"2014","unstructured":"de Sousa G, Nawaz A, Cravedi JP, Rahmani R (2014) A concentration addition model to assess activation of the pregnane X receptor (PXR) by pesticide mixtures found in the French diet. Toxicol Sci 141:234\u2013243. https:\/\/doi.org\/10.1093\/toxsci\/kfu120","journal-title":"Toxicol Sci"},{"key":"2997_CR11","doi-asserted-by":"publisher","unstructured":"ECHA (2017) Guidance on the Biocidal Products Regulation European Chemicals Agancy Volume III Human Health, Assessment & Evaluation (Parts b+C) doi: https:\/\/doi.org\/10.2823\/143042","DOI":"10.2823\/143042"},{"key":"2997_CR12","doi-asserted-by":"publisher","first-page":"110r","DOI":"10.2903\/j.efsa.2007.110r","volume":"5","author":"EFSA","year":"2007","unstructured":"EFSA (2007) Conclusion regarding the peer review of the pesticide risk assessment of the active substance fludioxonil. EFSA J 5:110r. https:\/\/doi.org\/10.2903\/j.efsa.2007.110r","journal-title":"EFSA J"},{"key":"2997_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2903\/j.efsa.2009.1167","volume":"7","author":"EFSA","year":"2009","unstructured":"EFSA (2009) Scientific opinion on risk assessment for a selected group of pesticides from the triazole group to test possible methodologies to assess cumulative effects from exposure through food from these pesticides on human health. EFSA J 7:1167. https:\/\/doi.org\/10.2903\/j.efsa.2009.1167","journal-title":"EFSA J"},{"key":"2997_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0742-8413(98)10133-0","volume":"122","author":"E Egaas","year":"1999","unstructured":"Egaas E, Sandvik M, Fjeld E, K\u00e4llqvist T, Goks\u00f8yr A, Svensen A (1999) Some effects of the fungicide propiconazole on cytochrome P450 and glutathione S-transferase in brown trout (Salmo trutta). Comp Biochem Physiol Part C Pharmacol Toxicol Endocrinol 122:337\u2013344. https:\/\/doi.org\/10.1016\/S0742-8413(98)10133-0","journal-title":"Comp Biochem Physiol Part C Pharmacol Toxicol Endocrinol"},{"key":"2997_CR15","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.bbadis.2017.12.032","volume":"1864","author":"S Ferdinandusse","year":"2018","unstructured":"Ferdinandusse S et al (2018) A novel case of ACOX2 deficiency leads to recognition of a third human peroxisomal acyl-CoA oxidase. Biochim Biophys Acta (BBA) Mol Basis Dis 1864:952\u2013958. https:\/\/doi.org\/10.1016\/j.bbadis.2017.12.032","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"2997_CR16","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.149","volume":"3","author":"J Foucquier","year":"2015","unstructured":"Foucquier J, Guedj M (2015) Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect 3:e00149\u2013e00149. https:\/\/doi.org\/10.1002\/prp2.149","journal-title":"Pharmacol Res Perspect"},{"key":"2997_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0168-8278(97)80496-5","volume":"26","author":"B Fromenty","year":"1997","unstructured":"Fromenty B, Pessayre D (1997) Impaired mitochondrial function in microvesicular steatosis effects of drugs, ethanol, hormones and cytokines. J Hepatol 26:43\u201353. https:\/\/doi.org\/10.1016\/S0168-8278(97)80496-5","journal-title":"J Hepatol"},{"key":"2997_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/toxsci\/kfp098","volume":"110","author":"AK Goetz","year":"2009","unstructured":"Goetz AK, Dix DJ (2009) Mode of action for reproductive and hepatic toxicity inferred from a genomic study of triazole antifungals. Toxicol Sci 110:449\u2013462. https:\/\/doi.org\/10.1093\/toxsci\/kfp098","journal-title":"Toxicol Sci"},{"key":"2997_CR19","doi-asserted-by":"publisher","first-page":"15655","DOI":"10.1073\/pnas.232137699","volume":"99","author":"P Gripon","year":"2002","unstructured":"Gripon P et al (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99:15655\u201315660. https:\/\/doi.org\/10.1073\/pnas.232137699","journal-title":"Proc Natl Acad Sci USA"},{"key":"2997_CR20","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1517\/14656566.6.13.2231","volume":"6","author":"PO Gubbins","year":"2005","unstructured":"Gubbins PO, Amsden JR (2005) Drug-drug interactions of antifungal agents and implications for patient care. Expert Opin Pharmacother 6:2231\u20132243. https:\/\/doi.org\/10.1517\/14656566.6.13.2231","journal-title":"Expert Opin Pharmacother"},{"key":"2997_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ecoenv.2019.05.071","volume":"181","author":"MD Habenschus","year":"2019","unstructured":"Habenschus MD, Nardini V, Dias LG, Rocha BA, Barbosa F, de Oliveira ARM (2019) vitro enantioselective study of the toxicokinetic effects of chiral fungicide tebuconazole in human liver microsomes. Ecotoxicol Environ Saf 181:96\u2013105. https:\/\/doi.org\/10.1016\/j.ecoenv.2019.05.071","journal-title":"Ecotoxicol Environ Saf"},{"key":"2997_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ab.2006.04.046","volume":"356","author":"M Hampf","year":"2006","unstructured":"Hampf M, Gossen M (2006) A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays. Anal Biochem 356:94\u201399. https:\/\/doi.org\/10.1016\/j.ab.2006.04.046","journal-title":"Anal Biochem"},{"key":"2997_CR23","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1007\/s00204-017-2043-5","volume":"91","author":"AF Hern\u00e1ndez","year":"2017","unstructured":"Hern\u00e1ndez AF, Gil F, Lacasa\u00f1a M (2017) Toxicological interactions of pesticide mixtures: an update. Arch Toxicol 91:3211\u20133223. https:\/\/doi.org\/10.1007\/s00204-017-2043-5","journal-title":"Arch Toxicol"},{"key":"2997_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jcmgh.2015.05.006","volume":"1","author":"S Joshi-Barve","year":"2015","unstructured":"Joshi-Barve S, Kirpich I, Cave MC, Marsano LS, McClain CJ (2015) Alcoholic, nonalcoholic, and toxicant-associated steatohepatitis: mechanistic similarities and differences cellular and molecular. Gastroenterol Hepatol 1:356\u2013367. https:\/\/doi.org\/10.1016\/j.jcmgh.2015.05.006","journal-title":"Gastroenterol Hepatol"},{"key":"2997_CR25","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00204-019-02445-2","volume":"93","author":"C Knebel","year":"2019","unstructured":"Knebel C, Buhrke T, Sussmuth R, Lampen A, Marx-Stoelting P, Braeuning A (2019a) Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines. Arch Toxicol 93:1311\u20131322. https:\/\/doi.org\/10.1007\/s00204-019-02445-2","journal-title":"Arch Toxicol"},{"key":"2997_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.fct.2018.11.039","volume":"123","author":"C Knebel","year":"2019","unstructured":"Knebel C, Heise T, Zanger UM, Lampen A, Marx-Stoelting P, Braeuning A (2019b) The azole fungicide tebuconazole affects human CYP1A1 and CYP1A2 expression by an aryl hydrocarbon receptor-dependent pathway. Food Chem Toxicol 123:481\u2013491. https:\/\/doi.org\/10.1016\/j.fct.2018.11.039","journal-title":"Food Chem Toxicol"},{"key":"2997_CR27","doi-asserted-by":"publisher","first-page":"113953","DOI":"10.1016\/j.envpol.2020.113953","volume":"260","author":"A Lasch","year":"2020","unstructured":"Lasch A, Lichtenstein D, Marx-Stoelting P, Braeuning A, Alarcan J (2020b) Mixture effects of chemicals: the difficulty to choose appropriate mathematical models for appropriate conclusions. Environ Pollut 260:113953. https:\/\/doi.org\/10.1016\/j.envpol.2020.113953","journal-title":"Environ Pollut"},{"key":"2997_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02685-7","author":"A Lasch","year":"2020","unstructured":"Lasch A, Alarcan J, Lampen A, Braeuning A, Lichtenstein D (2020a) Combinations of LXR and RXR agonists induce triglyceride accumulation in human HepaRG cells in a synergistic manner. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-020-02685-7","journal-title":"Arch Toxicol"},{"key":"2997_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative pcr and the 2\u2212\u0394\u0394CT method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"2997_CR30","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M (2016) Carnitine transport and fatty acid oxidation. Biochem Biophys Acta 1863:2422\u20132435. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.023","journal-title":"Biochem Biophys Acta"},{"key":"2997_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.toxlet.2013.06.243","volume":"222","author":"C Luckert","year":"2013","unstructured":"Luckert C, Ehlers A, Buhrke T, Seidel A, Lampen A, Hessel S (2013) Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR. Toxicol Lett 222:180\u2013188","journal-title":"Toxicol Lett"},{"key":"2997_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00204-016-1677-z","volume":"91","author":"C Luckert","year":"2017","unstructured":"Luckert C et al (2017) Comparative analysis of 3D culture methods on human HepG2 cells. Arch Toxicol 91:393\u2013406. https:\/\/doi.org\/10.1007\/s00204-016-1677-z","journal-title":"Arch Toxicol"},{"key":"2997_CR33","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1021\/acs.chemrestox.8b00112","volume":"31","author":"C Luckert","year":"2018","unstructured":"Luckert C et al (2018) Adverse outcome pathway-driven analysis of liver steatosis in vitro: a case study with cyproconazole. Chem Res Toxicol 31:784\u2013798. https:\/\/doi.org\/10.1021\/acs.chemrestox.8b00112","journal-title":"Chem Res Toxicol"},{"key":"2997_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051192","author":"P Marx-Stoelting","year":"2020","unstructured":"Marx-Stoelting P, Knebel C, Braeuning A (2020) The connection of Azole fungicides with xeno-sensing nuclear receptors. Drug Metab Hepat Cells. https:\/\/doi.org\/10.3390\/cells9051192","journal-title":"Drug Metab Hepat Cells"},{"key":"2997_CR35","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1021\/es072049b","volume":"42","author":"CS Mazur","year":"2008","unstructured":"Mazur CS, Kenneke JF (2008) Cross-species comparison of conazole fungicide metabolites using rat and rainbow trout (Onchorhynchus mykiss) hepatic microsomes and purified human CYP 3A4. Environ Sci Technology 42:947\u2013954. https:\/\/doi.org\/10.1021\/es072049b","journal-title":"Environ Sci Technology"},{"key":"2997_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/10408444.2015.1089471","volume":"46","author":"CL Mellor","year":"2016","unstructured":"Mellor CL, Steinmetz FP, Cronin MT (2016) The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways. Crit Rev Toxicol 46:138\u2013152. https:\/\/doi.org\/10.3109\/10408444.2015.1089471","journal-title":"Crit Rev Toxicol"},{"key":"2997_CR37","doi-asserted-by":"publisher","first-page":"e05634","DOI":"10.2903\/j.efsa.2019.5634","volume":"17","author":"SJ More","year":"2019","unstructured":"More SJ et al (2019) Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals. EFSA J 17:e05634. https:\/\/doi.org\/10.2903\/j.efsa.2019.5634","journal-title":"EFSA J"},{"key":"2997_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/toxsci\/kfp076","volume":"110","author":"S Nesnow","year":"2009","unstructured":"Nesnow S, Ward W, Moore T, Ren H, Hester SD (2009) Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression. Toxicology Sci 110:68\u201383. https:\/\/doi.org\/10.1093\/toxsci\/kfp076","journal-title":"Toxicology Sci"},{"key":"2997_CR39","doi-asserted-by":"publisher","first-page":"269E","DOI":"10.2903\/sp.efsa.2012.EN-269","volume":"9","author":"E Nielsen","year":"2012","unstructured":"Nielsen E et al (2012) Identification of cumulative assessment groups of pesticides. EFSA Support Publ 9:269E. https:\/\/doi.org\/10.2903\/sp.efsa.2012.EN-269","journal-title":"EFSA Support Publ"},{"key":"2997_CR40","unstructured":"OECD (2018) Consideration for assessing the risks of combined exposure to multiple chemicals environment, Health and Sfety Division, Environment Directorate Series on Testing and Assessment No. 296"},{"key":"2997_CR41","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","volume":"23","author":"BJ Perumpail","year":"2017","unstructured":"Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A (2017) Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol 23:8263\u20138276. https:\/\/doi.org\/10.3748\/wjg.v23.i47.8263","journal-title":"World J Gastroenterol"},{"key":"2997_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cbi.2008.10.052","volume":"179","author":"L Pochini","year":"2009","unstructured":"Pochini L, Scalise M, Indiveri C (2009) Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes. Chem Biol Interact 179:394\u2013401. https:\/\/doi.org\/10.1016\/j.cbi.2008.10.052","journal-title":"Chem Biol Interact"},{"key":"2997_CR43","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/10408444.2018.1541964","volume":"48","author":"S Rotter","year":"2018","unstructured":"Rotter S et al (2018) Overview on legislation and scientific approaches for risk assessment of combined exposure to multiple chemicals: the potential EuroMix contribution. Crit Rev Toxicol 48:796\u2013814. https:\/\/doi.org\/10.1080\/10408444.2018.1541964","journal-title":"Crit Rev Toxicol"},{"key":"2997_CR44","doi-asserted-by":"publisher","first-page":"e14584","DOI":"10.1371\/journal.pone.0014584","volume":"6","author":"I Shah","year":"2011","unstructured":"Shah I et al (2011) Using nuclear receptor activity to stratify hepatocarcinogens. PLoS ONE 6:e14584. https:\/\/doi.org\/10.1371\/journal.pone.0014584","journal-title":"PLoS ONE"},{"key":"2997_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1124\/dmd.117.078675","volume":"46","author":"N Tanner","year":"2018","unstructured":"Tanner N et al (2018) Regulation of drug metabolism by the interplay of inflammatory signaling steatosis, and xeno-sensing receptors in HepaRG cells. Drug Metab Dispos 46:326\u2013335. https:\/\/doi.org\/10.1124\/dmd.117.078675","journal-title":"Drug Metab Dispos"},{"key":"2997_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2016.04.007","volume":"302","author":"L Tolosa","year":"2016","unstructured":"Tolosa L, Gomez-Lechon MJ, Jimenez N, Hervas D, Jover R, Donato MT (2016) Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis. Toxicol Appl Pharmacol 302:1\u20139. https:\/\/doi.org\/10.1016\/j.taap.2016.04.007","journal-title":"Toxicol Appl Pharmacol"},{"key":"2997_CR47","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.taap.2006.02.015","volume":"215","author":"DB Tully","year":"2006","unstructured":"Tully DB et al (2006) Gene expression profiling in liver and testis of rats to characterize the toxicity of triazole fungicides. Toxicol Appl Pharmacol 215:260\u2013273. https:\/\/doi.org\/10.1016\/j.taap.2006.02.015","journal-title":"Toxicol Appl Pharmacol"},{"key":"2997_CR48","doi-asserted-by":"publisher","first-page":"10335","DOI":"10.1016\/S0021-9258(18)82206-2","volume":"268","author":"GF Vanhove","year":"1993","unstructured":"Vanhove GF, Van Veldhoven PP, Fransen M, Denis S, Eyssen HJ, Wanders RJ, Mannaerts GP (1993) The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidney. J Biol Chem 268:10335\u201310344","journal-title":"J Biol Chem"},{"key":"2997_CR49","doi-asserted-by":"publisher","first-page":"11289","DOI":"10.1073\/pnas.1613228113","volume":"113","author":"S Vilarinho","year":"2016","unstructured":"Vilarinho S et al (2016) ACOX2 deficiency: a disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment. Proc Natl Acad Sci USA 113:11289\u201311293. https:\/\/doi.org\/10.1073\/pnas.1613228113","journal-title":"Proc Natl Acad Sci USA"},{"key":"2997_CR50","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","volume":"142","author":"DL Villeneuve","year":"2014","unstructured":"Villeneuve DL et al (2014) Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci 142:312\u2013320. https:\/\/doi.org\/10.1093\/toxsci\/kfu199","journal-title":"Toxicol Sci"},{"key":"2997_CR51","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/acs.chemrestox.5b00208","volume":"28","author":"M Vinken","year":"2015","unstructured":"Vinken M (2015) Adverse outcome pathways and drug-induced liver injury testing. Chem Res Toxicol 28:1391\u20131397. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00208","journal-title":"Chem Res Toxicol"},{"key":"2997_CR52","doi-asserted-by":"publisher","first-page":"114105","DOI":"10.1016\/j.envpol.2020.114105","volume":"260","author":"Y Wang","year":"2020","unstructured":"Wang Y et al (2020) Combined toxic effects of fludioxonil and triadimefon on embryonic development of zebrafish (Danio rerio). Environ Pollut 260:114105. https:\/\/doi.org\/10.1016\/j.envpol.2020.114105","journal-title":"Environ Pollut"},{"key":"2997_CR53","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/toxsci\/kfu169","volume":"142","author":"BA Wetmore","year":"2014","unstructured":"Wetmore BA et al (2014) Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing. Toxicol Sci 142:210\u2013224. https:\/\/doi.org\/10.1093\/toxsci\/kfu169","journal-title":"Toxicol Sci"},{"key":"2997_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/tox.22575","author":"JD Yang","year":"2018","unstructured":"Yang JD, Liu SH, Liao MH, Chen RM, Liu PY, Ueng TH (2018) Effects of tebuconazole on cytochrome P450 enzymes, oxidative stress, and endocrine disruption in male rats. Environ Toxicol. https:\/\/doi.org\/10.1002\/tox.22575","journal-title":"Environ Toxicol"},{"key":"2997_CR55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jes.2016.03.011","volume":"52","author":"L Zhang","year":"2017","unstructured":"Zhang L, Dong X, Wang C, Zuo Z, Chen M (2017) Bioaccumulation and the expression of hepatic cytochrome P450 genes in marine medaka (Oryzias melastigma) exposed to difenoconazole. J Environ Sci 52:98\u2013104. https:\/\/doi.org\/10.1016\/j.jes.2016.03.011","journal-title":"J Environ Sci"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-02997-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-021-02997-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-02997-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T06:05:20Z","timestamp":1617861920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-021-02997-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2997"],"URL":"https:\/\/doi.org\/10.1007\/s00204-021-02997-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}